These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7743085)

  • 1. Cellular and molecular biology of Alzheimer's disease and animal models.
    Sisodia SS; Martin LJ; Walker LC; Borchelt DR; Price DL
    Neuroimaging Clin N Am; 1995 Feb; 5(1):59-68. PubMed ID: 7743085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular and molecular biology of Alzheimer's disease and animal models.
    Price DL; Sisodia SS
    Annu Rev Med; 1994; 45():435-46. PubMed ID: 8198393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Making models for Alzheimer's disease.
    Lamb BT
    Nat Genet; 1995 Jan; 9(1):4-6. PubMed ID: 7704022
    [No Abstract]   [Full Text] [Related]  

  • 4. Homology of the amyloid beta protein precursor in monkey and human supports a primate model for beta amyloidosis in Alzheimer's disease.
    Podlisny MB; Tolan DR; Selkoe DJ
    Am J Pathol; 1991 Jun; 138(6):1423-35. PubMed ID: 1905108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular biology of the amyloid of Alzheimer's disease. An overview.
    Inestrosa NC; Soto C
    Biol Res; 1992; 25(2):63-72. PubMed ID: 1365703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathogenesis of beta-amyloidosis in Alzheimer's disease and other cerebral amyloidoses.
    Maury CP
    Lab Invest; 1995 Jan; 72(1):4-16. PubMed ID: 7837789
    [No Abstract]   [Full Text] [Related]  

  • 7. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease. Mouse model made.
    Duff K; Hardy J
    Nature; 1995 Feb; 373(6514):476-7. PubMed ID: 7845455
    [No Abstract]   [Full Text] [Related]  

  • 9. A mutation protective against Alzheimer's disease renders amyloid β precursor protein incapable of mediating neurotoxicity.
    Hashimoto Y; Matsuoka M
    J Neurochem; 2014 Jul; 130(2):291-300. PubMed ID: 24646423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease. Molecular genetics.
    Hardy J
    J Fla Med Assoc; 1994 Nov; 81(11):759-61. PubMed ID: 7815043
    [No Abstract]   [Full Text] [Related]  

  • 11. Alzheimer's disease untangled.
    Crawford F; Goate A
    Bioessays; 1992 Nov; 14(11):727-34. PubMed ID: 1365885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on the amyloid hypothesis.
    Eckman CB; Eckman EA
    Neurol Clin; 2007 Aug; 25(3):669-82, vi. PubMed ID: 17659184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloidogenesis in Alzheimer's disease: some possible therapeutic opportunities.
    Gandy S; Greengard P
    Trends Pharmacol Sci; 1992 Mar; 13(3):108-13. PubMed ID: 1574806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid plaques, neurofibrillary tangles and neuronal loss in brains of transgenic mice overexpressing a C-terminal fragment of human amyloid precursor protein.
    Kawabata S; Higgins GA; Gordon JW
    Nature; 1991 Dec; 354(6353):476-8. PubMed ID: 1793460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's research moves to mice.
    Marx J
    Science; 1991 Jul; 253(5017):266-7. PubMed ID: 1907022
    [No Abstract]   [Full Text] [Related]  

  • 16. Cellular prion protein modulates β-amyloid deposition in aged APP/PS1 transgenic mice.
    Ordóñez-Gutiérrez L; Torres JM; Gavín R; Antón M; Arroba-Espinosa AI; Espinosa JC; Vergara C; Del Río JA; Wandosell F
    Neurobiol Aging; 2013 Dec; 34(12):2793-804. PubMed ID: 23831375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geniposide attenuates insulin-deficiency-induced acceleration of β-amyloidosis in an APP/PS1 transgenic model of Alzheimer's disease.
    Zhang Y; Yin F; Liu J; Liu Z; Guo L; Xia Z; Zidichouski J
    Neurochem Int; 2015 Oct; 89():7-16. PubMed ID: 25882165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
    Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S
    J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer's disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition.
    Stumm C; Hiebel C; Hanstein R; Purrio M; Nagel H; Conrad A; Lutz B; Behl C; Clement AB
    Neurobiol Aging; 2013 Nov; 34(11):2574-84. PubMed ID: 23838176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lewy bodies in Alzheimer's disease in which the primary lesion is a mutation in the amyloid precursor protein.
    Hardy J
    Neurosci Lett; 1994 Oct; 180(2):290-1. PubMed ID: 7700596
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.